{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:38Z","timestamp":1790716958768,"version":"4.1.0"},"reference-count":91,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.22092","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T11:33:40Z","timestamp":1658144020000},"page":"e2222092","source":"Crossref","is-referenced-by-count":37,"title":["Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care"],"prefix":"10.1001","volume":"5","author":[{"given":"Rita","family":"Kukafka","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"},{"name":"Herbert Irving Comprehensive Cancer, Columbia University Irving Medical Center, New York, New York"},{"name":"Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Pan","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Silverman","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer, Columbia University Irving Medical Center, New York, New York"},{"name":"Department of Pediatrics and Medicine, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Terry","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer, Columbia University Irving Medical Center, New York, New York"},{"name":"Department of Epidemiology, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Fleck","sequence":"additional","affiliation":[{"name":"Division of Community and Population Health, New York Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Younge","sequence":"additional","affiliation":[{"name":"Division of Community and Population Health, New York Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna S.","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer, Columbia University Irving Medical Center, New York, New York"},{"name":"Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"McGuinness","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer, Columbia University Irving Medical Center, New York, New York"},{"name":"Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"He","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Dimond","sequence":"additional","affiliation":[{"name":"Sassafras Collective, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Crew","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer, Columbia University Irving Medical Center, New York, New York"},{"name":"Department of Epidemiology, Columbia University Irving Medical Center, New York, New York"},{"name":"Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"5","key":"zoi220625r1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes - association analysis in more than 113,000 women.","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi220625r2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer.","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi220625r3","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"zoi220625r4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases.","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","journal-title":"Br J Cancer"},{"issue":"10","key":"zoi220625r5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186043","article-title":"Prevalence of deleterious germline variants in risk genes including BRCA1\/2 in consecutive ovarian cancer patients (AGO-TR-1).","volume":"12","author":"Harter","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"zoi220625r6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0215(20000701)87:1<110::AID-IJC16>3.0.CO;2-6","article-title":"Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.","volume":"87","author":"Sutcliffe","year":"2000","journal-title":"Int J Cancer"},{"issue":"4","key":"zoi220625r7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.SLA.0000059969.64262.87","article-title":"Rating the risk factors for breast cancer.","volume":"237","author":"Singletary","year":"2003","journal-title":"Ann Surg"},{"issue":"1","key":"zoi220625r8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016.","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"zoi220625r9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force Recommendation Statement.","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"23","key":"zoi220625r10","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"zoi220625r11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"zoi220625r12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of mutations in BRCA1 and BRCA2 in a population based series of breast cancer cases.","volume":"83","author":"Anglian","year":"2000","journal-title":"Br J Cancer"},{"issue":"2","key":"zoi220625r13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"zoi220625r14","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","article-title":"Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.","volume":"29","author":"Warner","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"zoi220625r15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","article-title":"Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.","volume":"148","author":"Warner","year":"2008","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi220625r16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ejso.2008.03.002","article-title":"Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.","volume":"34","author":"Isern","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"zoi220625r17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi220625r18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi220625r19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"issue":"9","key":"zoi220625r20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"zoi220625r21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SLA.0b013e3181c3c36d","article-title":"Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.","volume":"251","author":"Kaas","year":"2010","journal-title":"Ann Surg"},{"issue":"15","key":"zoi220625r22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"18","key":"zoi220625r23","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.","volume":"286","author":"King","year":"2001","journal-title":"JAMA"},{"issue":"9245","key":"zoi220625r24","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"zoi220625r25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"zoi220625r26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi220625r27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi220625r28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1055-9965.EPI-12-1280","article-title":"Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.","volume":"22","author":"Bellcross","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi220625r29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cge.12868","article-title":"Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review.","volume":"92","author":"Willis","year":"2017","journal-title":"Clin Genet"},{"issue":"5","key":"zoi220625r30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1055-9965.EPI-05-0002","article-title":"Uptake rates for breast cancer genetic testing: a systematic review.","volume":"15","author":"Ropka","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"zoi220625r31","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11606-009-1009-6","article-title":"Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.","volume":"24","author":"Levy","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"3-4","key":"zoi220625r33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000336419","article-title":"Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.","volume":"15","author":"Joseph","year":"2012","journal-title":"Public Health Genomics"},{"issue":"6","key":"zoi220625r34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/GIM.0b013e3181770184","article-title":"Differential use of available genetic tests among primary care physicians in the United States: results of a national survey.","volume":"10","author":"Shields","year":"2008","journal-title":"Genet Med"},{"issue":"14","key":"zoi220625r35","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2006.05.5889","article-title":"Disparities in genetic testing: thinking outside the BRCA box.","volume":"24","author":"Hall","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi220625r37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/gtmb.2012.0381","article-title":"A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.","volume":"17","author":"Pal","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"issue":"10","key":"zoi220625r38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/GIM.0b013e3181b2e5eb","article-title":"Breast cancer risk communication: assessment of primary care physicians by standardized patients.","volume":"11","author":"Culver","year":"2009","journal-title":"Genet Med"},{"issue":"23","key":"zoi220625r39","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1002\/cncr.26166","article-title":"Reported referral for genetic counseling or BRCA 1\/2 testing among United States physicians: a vignette-based study.","volume":"117","author":"Trivers","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"zoi220625r40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amepre.2010.09.027","article-title":"Awareness and utilization of BRCA1\/2 testing among U.S. primary care physicians.","volume":"40","author":"Bellcross","year":"2011","journal-title":"Am J Prev Med"},{"issue":"1","key":"zoi220625r41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13187-015-0950-9","article-title":"Georgia primary care providers\u2019 knowledge of hereditary breast and ovarian cancer syndrome.","volume":"32","author":"Nair","year":"2017","journal-title":"J Cancer Educ"},{"issue":"2","key":"zoi220625r42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.GIM.0000055201.16487.61","article-title":"Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature.","volume":"5","author":"Suther","year":"2003","journal-title":"Genet Med"},{"issue":"3","key":"zoi220625r43","first-page":"174","article-title":"The comprehensiveness of family cancer history assessments in primary care.","volume":"10","author":"Murff","year":"2007","journal-title":"Community Genet"},{"issue":"3","key":"zoi220625r44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1377\/hlthaff.26.3.741","article-title":"Numeracy skill and the communication, comprehension, and use of risk-benefit information.","volume":"26","author":"Peters","year":"2007","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"zoi220625r45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11606-007-0142-3","article-title":"Are physicians discussing prostate cancer screening with their patients and why or why not? a pilot study.","volume":"22","author":"Guerra","year":"2007","journal-title":"J Gen Intern Med"},{"key":"zoi220625r46","first-page":"1352","article-title":"Barriers and facilitators to patient-provider communication when discussing breast cancer risk to aid in the development of decision support tools.","volume":"2015","author":"Yi","year":"2015","journal-title":"AMIA Annu Symp Proc"},{"key":"zoi220625r47","first-page":"58","article-title":"Introducing a comprehensive informatics framework to promote breast cancer risk assessment and chemoprevention in the primary care setting.","volume":"2017","author":"Finkelstein","year":"2017","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"issue":"1","key":"zoi220625r49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12911-018-0716-5","article-title":"Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting.","volume":"18","author":"Kukafka","year":"2018","journal-title":"BMC Med Inform Decis Mak"},{"issue":"7","key":"zoi220625r50","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.4028","article-title":"Why breast cancer risk by the numbers is not enough: evaluation of a decision aid in multi-ethnic, low-numerate women.","volume":"17","author":"Kukafka","year":"2015","journal-title":"J Med Internet Res"},{"issue":"1","key":"zoi220625r51","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12913-018-3442-x","article-title":"Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1\/2 genetic counseling referral in primary care.","volume":"18","author":"Silverman","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"29","key":"zoi220625r53","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2006.10.4703","article-title":"BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.","volume":"25","author":"Vogel","year":"2007","journal-title":"J Clin Oncol"},{"key":"zoi220625r54","first-page":"58","article-title":"Introducing a Comprehensive Informatics Framework to Promote Breast Cancer Risk Assessment and Chemoprevention in the Primary Care Setting.","volume":"2017","author":"Finkelstein","year":"2017","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"zoi220625r55","first-page":"961","article-title":"An applied framework in support of shared decision making about BRCA genetic testing.","volume":"2018","author":"Silverman","year":"2018","journal-title":"AMIA Annu Symp Proc"},{"issue":"5","key":"zoi220625r56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11606-008-0520-5","article-title":"Validation of screening questions for limited health literacy in a large VA outpatient population.","volume":"23","author":"Chew","year":"2008","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi220625r57","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.8.4.e27","article-title":"eHEALS: The eHealth Literacy Scale.","volume":"8","author":"Norman","year":"2006","journal-title":"J Med Internet Res"},{"issue":"5","key":"zoi220625r58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0272989X07303824","article-title":"Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations.","volume":"27","author":"Zikmund-Fisher","year":"2007","journal-title":"Med Decis Making"},{"issue":"2","key":"zoi220625r59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/07399863870092005","article-title":"Development of a short acculturation scale for Hispanics.","volume":"9","author":"Marin","year":"1987","journal-title":"Hisp J Behav Sci"},{"issue":"3","key":"zoi220625r60","first-page":"21","article-title":"The Control Preferences Scale.","volume":"29","author":"Degner","year":"1997","journal-title":"Can J Nurs Res"},{"issue":"3","key":"zoi220625r61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1077558702059003004","article-title":"Measuring patients\u2019 trust in their primary care providers.","volume":"59","author":"Hall","year":"2002","journal-title":"Med Care Res Rev"},{"issue":"24","key":"zoi220625r62","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","article-title":"BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.","volume":"275","author":"Lerman","year":"1996","journal-title":"JAMA"},{"issue":"10","key":"zoi220625r64","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-05-0482","article-title":"Measuring perceptions of breast cancer risk.","volume":"15","author":"Gurmankin Levy","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"zoi220625r65","first-page":"171","article-title":"Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.","author":"Lerman","year":"1994","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"zoi220625r67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1369-6513.2001.00140.x","article-title":"A measure of informed choice.","volume":"4","author":"Marteau","year":"2001","journal-title":"Health Expect"},{"issue":"1","key":"zoi220625r68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cncr.33866","article-title":"Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.","volume":"128","author":"Arun","year":"2022","journal-title":"Cancer"},{"issue":"18","key":"zoi220625r69","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1002\/cncr.31635","article-title":"A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.","volume":"124","author":"Hoskins","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"zoi220625r70","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10897-016-0050-y","article-title":"Breast cancer risk assessment at the time of screening mammography: perceptions and clinical management outcomes for women at high risk.","volume":"26","author":"Morman","year":"2017","journal-title":"J Genet Couns"},{"issue":"4","key":"zoi220625r71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10689-020-00176-3","article-title":"Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients.","volume":"19","author":"van der Giessen","year":"2020","journal-title":"Fam Cancer"},{"issue":"8","key":"zoi220625r72","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1089\/jwh.2019.7984","article-title":"Reducing disparities in receipt of genetic counseling for underserved women at risk of hereditary breast and ovarian cancer.","volume":"29","author":"Sutton","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"issue":"10","key":"zoi220625r73","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2105\/AJPH.2016.303312","article-title":"Effective referral of low-income women at risk for hereditary breast and ovarian cancer to genetic counseling: a randomized delayed intervention control trial.","volume":"106","author":"Pasick","year":"2016","journal-title":"Am J Public Health"},{"key":"zoi220625r74","doi-asserted-by":"crossref","DOI":"10.1080\/17437199.2021.1980083","article-title":"Decision-making about genetic health information among family dyads: a systematic literature review.","author":"Law","year":"2021","journal-title":"Health Psychol Rev"},{"issue":"2","key":"zoi220625r75","article-title":"Intergenerational decision making: the role of family relationships in medical decision making.","volume":"6","author":"Lin","year":"2021","journal-title":"MDM Policy Pract"},{"issue":"4","key":"zoi220625r76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41431-021-01008-3","article-title":"Genetic testing decisions in non-western cultures: an opportunity for intergenerational decision making.","volume":"30","author":"Turbitt","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"zoi220625r77","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.pec.2017.11.016","article-title":"Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer.","volume":"101","author":"Grimmett","year":"2018","journal-title":"Patient Educ Couns"},{"issue":"5","key":"zoi220625r78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amepre.2014.01.002","article-title":"Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.","volume":"46","author":"Mai","year":"2014","journal-title":"Am J Prev Med"},{"issue":"1","key":"zoi220625r79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11606-020-06064-x","article-title":"Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center.","volume":"36","author":"Chapman-Davis","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"11","key":"zoi220625r80","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/1055-9965.EPI-15-0293","article-title":"Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.","volume":"24","author":"Chen","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"zoi220625r81","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016.","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"zoi220625r82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3322\/caac.21320","article-title":"Breast cancer statistics, 2015: Convergence of incidence rates between Black and White women.","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"zoi220625r83","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10549-010-1191-6","article-title":"Disparities in breast cancer characteristics and outcomes by race\/ethnicity.","volume":"127","author":"Ooi","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"zoi220625r84","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3322\/caac.21412","article-title":"Breast cancer statistics, 2017, racial disparity in mortality by state.","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"zoi220625r85","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jamia\/ocaa273","article-title":"Persistent inequitable design and implementation of patient portals for users at the margins.","volume":"28","author":"Goedhart","year":"2021","journal-title":"J Am Med Inform Assoc"},{"issue":"8","key":"zoi220625r86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203202","article-title":"Analysing mHealth usage logs in RCTs: explaining participants\u2019 interactions with type 2 diabetes self-management tools.","volume":"13","author":"Bradway","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"zoi220625r87","doi-asserted-by":"crossref","DOI":"10.2196\/mhealth.3882","article-title":"A mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes, part 2: one-year results from the Norwegian randomized controlled trial RENEWING HEALTH.","volume":"2","author":"Holmen","year":"2014","journal-title":"JMIR Mhealth Uhealth"},{"key":"zoi220625r88","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-5908-9-26","article-title":"Peering into the black box: a meta-analysis of how clinicians use decision aids during clinical encounters.","volume":"9","author":"Wyatt","year":"2014","journal-title":"Implement Sci"},{"issue":"3","key":"zoi220625r89","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10549-020-05975-x","article-title":"Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial.","volume":"185","author":"Raphael Daniela","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"zoi220625r90","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/0272989X20978208","article-title":"What works in implementing patient decision aids in routine clinical settings? a rapid realist review and update from the international patient decision aid standards collaboration.","volume":"41","author":"Joseph-Williams","year":"2021","journal-title":"Med Decis Making"},{"key":"zoi220625r91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12911-016-0273-8","article-title":"Wilfully out of sight? a literature review on the effectiveness of cancer-related decision aids and implementation strategies.","volume":"16","author":"Herrmann","year":"2016","journal-title":"BMC Med Inform Decis Mak"},{"key":"zoi220625r32","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.1586","volume-title":"Decision support for family history intake to determine eligibility for BRCA testing among multiethnic women","author":"McGuinness","year":"2017"},{"key":"zoi220625r36","author":"Yi","year":"2015"},{"key":"zoi220625r48","author":"Coe","year":"2016"},{"key":"zoi220625r52","first-page":"147","article-title":"Recent enhancements to the genetic risk prediction model BRCAPRO.","volume-title":"Cancer Inform","author":"Mazzola","year":"2015"},{"key":"zoi220625r63","unstructured":"O\u2019Connor? AM. User manual - decisional conflict scale. Published 1993. Accessed June 22, 2022. http:\/\/www.ohri.ca\/decisionaid"},{"key":"zoi220625r66","doi-asserted-by":"crossref","unstructured":"O\u2019Connor? A. User manual-decision self-efficacy scale. Patient Decision Aids, Ottawa Hospital Research Institute (OHIR). 1995. Accessed February 4, 2015. https:\/\/decisionaid.ohri.ca\/docs\/develop\/Tools\/Decision_SelfEfficacy.pdf","DOI":"10.1037\/t23888-000"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2794299\/kukafka_2022_oi_220625_1657299008.6754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T11:34:51Z","timestamp":1658144091000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2794299"}},"subtitle":["A Cluster Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.22092","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]}}}